Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA + arsenic trioxide protocol for acute promyelocytic leukemia
jRCTs071180040Completed
- Sponsor
- ICMR-Regional Medical Research Centre
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tretinoin and arsenic trioxide in Acute promyelocytic leukaemia (APL) (2 arms), sponsored by ICMR-Regional Medical Research Centre. Primary endpoint: 3-year disease-free survival. Started Mar 2017; status: completed.
02
Drugs
tretinoinarsenic trioxide
03
Conditions
Acute promyelocytic leukaemia (APL)
Beyond the preview
Go deeper on jRCTs071180040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180040.